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Research
Perchlorate (ClO4
–), a water-soluble chemical 
distributed extensively in the environment, 
has caused public health concerns because of 
widespread exposures to populations by inges-
tion of ClO4
–-contaminated food and water. 
The ClO4
– anion has recently been classified 
as a ubiquitous environmental contaminant 
throughout the United States, with detect-
able concentrations in many drinking water 
supplies (Motzer 2001) and food and bever-
age products (e.g., milk, lettuce, grains) (El 
Aribi et al. 2006), and is also found as a con-
taminant in dietary supplements (Snyder 
et al. 2006). The occurrence of ClO4
– in 
the environment is most often attributed to 
anthropogenic uses of ClO4
– salts as oxidiz-
ers in solid rocket propellants and application 
of Chilean nitrate fertilizers (Motzer 2001); 
however, ClO4
– is also formed naturally by 
atmospheric processes (Dasgupta et al. 2005). 
The primary health concern for environmental 
exposures to ClO4
– is adverse (and irrevers-
ible) neuro  developmental outcomes mediated 
by disruption of the hypothalamic–pituitary–
thyroid (HPT) axis in the immature fetus or 
child. Adequate levels of thyroid hormones 
are essential for proper growth, develop  ment, 
reproduction, and metabolism.
ClO4
– blocks thyroidal uptake of radio-
labeled iodide and alters thyroid hormone 
homeostasis [an increase in serum thyroid-
stimulating hormone (TSH) concentrations 
and a decline in serum thyroxine (T4) con-
centrations] (National Research Council 
2005; U.S. Environmental Protection Agency 
2002). Dietary iodide is an essential nutrient 
used in the formation of thyroid hormones, 
and if in short supply, from the blocking 
effect of ClO4
–, an iodide-deficiency–induced 
decrease in thyroid hormone production is 
thought to occur. For humans, under clini-
cal conditions, ClO4
– clearly inhibits thyroi-
dal uptake of radio  labeled iodide (Greer et al. 
2002); however, disruption of the HPT axis 
by ClO4
– remains to be clearly demonstrated 
in euthyroid adults. Interestingly, ClO4
– was 
used to treat thyrotoxicosis (overactive thy-
roid gland) with large doses, ranging from 
17–29 mg/kg, until several cases of fatal aplas-
tic anemia occurred in the early 1960s. The 
mechanism of action for this adverse effect 
of ClO4
– is unknown. ClO4
– was also used 
clinically to test thyroid function, referred 
to as the ClO4
– discharge test. For this test, 
radio  labeled tracer iodide is administered a 
few hours before dosing with 2–13 mg/kg 
ClO4
– (Wolff 1998), causing blocking of 
active uptake of radiolabeled iodide for several 
hours. By 2 hr after dosing, the thyroid gland 
has sequestered radio  labeled iodide, but circu-
lating levels of the iodide remain in the body 
and are available for sequestration into the 
thyroid gland. If the thyroid gland is defective 
in binding (trapping) iodide, rapid and exces-
sive efflux of radio  labeled iodide from the thy-
roid is observed in the presence of ClO4
–.
The primary mechanism by which 
ClO4
– blocks thyroidal uptake of iodide is 
competitive inhibition at the sodium/iodide 
symporter (NIS) protein. The NIS protein is 
responsible for active translocation of both 
iodide and ClO4
– from circulating blood to 
the thyroid follicle. Bidirectional passive diffu-
sion of iodide and ClO4
– also occurs between 
the thyroid gland and the blood supply per-
fusing the thyroid. When the ClO4
– discharge 
test is administered, a possible mechanism of 
action for efflux of radiolabeled iodide from 
defective thyroid glands may be simple dif-
fusion of radiolabeled iodide down a concen-
tration gradient from the thyroid gland into 
the blood supply because the NIS “pump” 
that maintains an iodide gradient between the 
blood and the thyroid gland is shut down by 
ClO4
–. A rapid efflux of radiolabeled iodide 
has been observed in cell preparations defi-
cient in the binding protein, thyroglobulin 
(Kosugi et al. 1996).
Several decades ago, in vitro studies were 
conducted in Sprague-Dawley rat thyroid 
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Ba c k g r o u n d: Perchlorate (ClO4
–) is an environmental contaminant known to disrupt the thyroid 
axis of many terrestrial and aquatic species. ClO4
– competitively inhibits iodide uptake into the 
thyroid at the sodium/iodide symporter and disrupts hypothalamic–pituitary–thyroid (HPT) axis 
homeostasis in rodents.
oB j e c t i v e: We evaluated the proposed mode of action for ClO4
–-induced rat HPT axis perturba-
tions using a biologically based dose–response (BBDR) model of the HPT axis coupled with a 
physiologically based pharmacokinetic model of ClO4
–.
Me t h o d s : We configured a BBDR-HPT/ClO4
– model to describe competitive inhibition of thyroidal 
uptake of dietary iodide by ClO4
– and used it to simulate published adult rat drinking water studies. 
We compared model-predicted serum thyroid-stimulating hormone (TSH) and total thyroxine (TT4) 
concentrations with experimental observations reported in these ClO4
– drinking water studies.
re s u l t s: The BBDR-HPT/ClO4
– model failed to predict the ClO4
–-induced onset of disturbances 
in the HPT axis. Using ClO4
– inhibition of dietary iodide uptake into the thyroid, the model 
underpredicted both the rapid decrease in serum TT4 concentrations and the rise in serum TSH 
concentrations.
co n c l u s i o n s: Assuming only competitive inhibition of thyroidal uptake of dietary iodide, BBDR-
HPT/ClO4
– model calculations were inconsistent with the rapid decrease in serum TT4 and the 
corresponding increase in serum TSH. Availability of bound iodide in the thyroid gland governed 
the rate of hormone secretion from the thyroid. ClO4
– is translocated into the thyroid gland, where 
it may act directly or indirectly on thyroid hormone synthesis/secretion in the rat. The rate of decline 
in serum TT4 in these studies after 1 day of treatment with ClO4
– appeared consistent with a reduc-
tion in thyroid hormone production/secretion. This research demonstrates the utility of a biologically 
based model to evaluate a proposed mode of action for ClO4
– in a complex biological process.
key  w o r d s : BBDR model, HPT axis, iodide, mode of action, PBPK model, perchlo-
rate, rat, sodium/iodide symporter, thyroid, thyroid hormone secretion. Environ Health Perspect 
117:731–738 (2009).  doi:10.1289/ehp.0800111 available via http://dx.doi.org/ [Online 5 January 2009]McLanahan et al.
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homogenates to examine the effects of anti-
thyroid compounds on iodide peroxidase 
activity (Alexander 1959). For each anti-
thyroid compound tested, thyroid homoge-
nates were incubated with 1 µmol potassium 
iodide (KI) and 2 × 10–3 M antithyroid com-
pound for 2 hr. Thiocyanate, thiouracil, and 
cyanide were several of the antithyroid com-
pounds shown to inhibit incorporation of 131I 
into l-tyrosine, decreasing the formation of 
monoiodotyrosine (MIT) and diiodo  tyrosine 
(DIT). However, ClO4
– did not signi  ficantly 
alter the synthesis of MIT and DIT. Thus, 
the data suggest that ClO4
– does not alter 
organification of iodide, which is a key step in 
thyroid hormone synthesis (Alexander 1959). 
Several years later, Greer et al. (1966) pro-
vided contradicting results, demonstrating a 
direct effect of ClO4
– on the rat thyroid gland 
in vitro. These authors reported that ClO4
– 
reduced formation of MIT and DIT in rat 
thyroid lobes when incubated with ClO4
–. 
They observed changes in MIT and DIT 
formation for ClO4
– media concentrations 
starting at 10 mg/L, with a reported 50% 
effective reduction of DIT at 250 mg/L.
In addition to ClO4
– acting at the NIS 
protein of the thyroid gland, a few other 
studies have demonstrated another poten-
tial mode of action (MOA) for high doses 
of ClO4
– to disrupt the HPT axis. Using an 
in vitro system and very high concentrations 
of ClO4
– (≥ 1,700 mg/L), Okabe and Hokaze 
(1993) reported that ClO4
– displaces T4 
bound to bovine serum albumin. This obser-
vation implies that free T4 (fT4) dislodged 
from serum proteins would then be cleared 
from the body more quickly, leading to a dis-
ruption of the HPT axis. In earlier in vivo 
studies, Yamada (1967), who was interested 
in this same MOA, removed the thyroid or 
gave methimazole [methylmercapto  imidazole 
(MMI)] to rats to inhibit thyroid function 
(and treated them with T4) and then evaluated 
the ClO4
– dose-dependent decline in serum 
protein-bound iodide (PBI; primarily radio-
labeled T4). The decline in serum PBI was 
interpreted as displacement of protein bound 
T4 by ClO4
–. The daily intake rates of ClO4
– 
were estimated to be 10–1,000 mg/kg/day.
Historically, pharmacokinetic or compu-
tational analyses of the HPT axis have played 
a prominent role in efforts to quantify and 
understand the complex relationships between 
biological action of thyroid hormones and 
their production, metabolism, transport, 
distribution, and interaction with receptors 
(DiStefano and Landaw 1984; Oppenheimer 
1983). Recently, physiologically based 
pharmaco  kinetic (PBPK) models were devel-
oped to describe the kinetics of ClO4
– and 
radio  labeled iodide and the interaction of 
ClO4
– on the thyroidal uptake of radiolabeled 
iodide in the adult rat (Fisher et al. 2000; 
Merrill et al. 2003). The rodent PBPK model 
described transport of ClO4
– into the thyroid 
gland by the NIS protein because high con-
centrations of ClO4
– were measured in thy-
roid tissue relative to serum (Yu et al. 2002). 
High concentrations of ClO4
– in the thyroid 
gland had also been observed in laboratory 
animals administered ClO4
– (Chow et al. 
1969; Chow and Woodbury 1970).
However, using an indirect electrochemi-
cal technique to infer movement of ClO4
– 
by the NIS into thyroid cells, Riedel et al. 
(2001) concluded that ClO4
– was not taken 
up into the thyroid gland because an electri-
cal gradient was not created. Evidence for 
ClO4
– movement into the thyroid gland 
was reviewed by Wolff (1998) and Clewell 
et al. (2004). Finally, a recent study directly 
meas  ured the TSH-mediated movement of 
ClO4
– into NIS-expressing FRTL-5 rat thy-
roid cells. This research provided conclusive 
evidence that the NIS protein did trans  locate 
ClO4
– into the thyroid cells (Tran et al. 
2008). At the same time, Dohan et al. (2007) 
concluded that ClO4
– is transferred by the 
NIS based on indirect lines of evidence using 
another anion (perrhenate) that is also trans-
ported with an electroneutral stoi  chiome  try 
into thyroid cells.
In the study we report here, using com-
putational analysis, we tested the hypothe-
sis that the primary MOA of ClO4
– on 
the HPT axis is competitive inhibition of 
uptake of thyroidal iodide. We combined 
our recently published biologically based 
dose–response (BBDR) model for the HPT 
axis (McLanahan et al. 2008), which we cal-
ibrated to describe perturbations resulting 
from dietary iodide deficiency, with a sim-
ple PBPK model for ClO4
–. The published 
ClO4
– dose–response data sets for the adult 
rat HPT axis (Männistö et al. 1979; Yu et al. 
2002) were simulated with our combined 
BBDR-HPT/ClO4
– models. Additionally, 
we conducted limited in vitro experiments 
at relevant ClO4
– plasma concentrations to 
evaluate the role of ClO4
– in displacement of 
T4 from serum-binding proteins.
Figure 1. BBDR model structure of the HPT axis for the description of dietary iodide, TSH, TT4, and TT3.
The model provides for recycling of dietary iodide released from metabolism of thyroid hormones (dashed 
lines), as well as the stimulation and regulation of the HPT axis by TSH. Numbers indicate several key 
processes: 1, loss of thyroidal-bound iodide secreted as thyroid hormones; 2, TSH stimulation of NIS iodide 
uptake, organification of iodide, and stimulation of thyroid hormone production; 3, T4 negative feedback on 
TSH production (thick solid lines); 4, formation of free iodide from serum and liver T3 and T4 metabolism; 
5, phase II metabolism of T4 and excretion into feces; and 6, fecal elimination of T3. For additional details 
on the BBDR-HPT axis model, see McLanahan et al. (2008). Bold arrows represent active transport and 
double thin arrows represent passive diffusion processes. Thin solid lines represent blood flows to or from 
the thyroid (QT) or the liver (QL). 
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Materials and Methods
Laboratory experiments. Displacement of T4 
from serum proteins. Radiolabeled L-[3´,5´-
125I]thyroxine (125I-T4; specific activity, 
1,500 µCi/µg; Perkin Elmer Life Sciences, 
Waltham, MA) was prepared by diluting 
25 µCi (0.5 mL of 50 µCi/mL solution) with 
1.0 mL 10% bovine serum albumin solution 
and predialyzing it against 2 mL 0.15 M phos-
phate buffer solution to reduce the amount 
of free 125I in the solution. We spiked male 
rat and male human serum (both obtained 
from Bioreclamation Inc., Hicksville, NY) 
with ClO4
– (Sigma Aldrich, Milwaukee, WI; 
0.01 mL ClO4
–/mL serum) diluted in saline 
to give a serum concentration of 0, 1.0, 10.0, 
50.0, 100, 200, or 300 µg/mL, vortexed the 
solution, and allowed it to stand for 30 min. 
We then added 0.02 mL (200,000–300,000 
cpm) predialyzed 125I-T4 solution/mL serum, 
vortexed the solution, and allowed it to stand 
for 30 min. One mL of spiked serum was 
dialyzed across a 6,000-kDa membrane over-
night against 1.0 mL 0.15 M phosphate buffer 
(pH 7.3) at 37°C in a gently shaking water 
bath. Serum and dialysate were removed from 
each half-cell with a Pasteur pipette precoated 
with carrier solution. We immediately placed 
750 µL dialysate into 750 µL carrier solu-
tion (3.0 mg/mL T4 and 3.72 mg/mL NaI 
in 0.5 M NaOH) and vortexed it. Volume 
recovered was assessed in order to account for 
possible fluid shifts across the membrane. The 
dialysate/carrier solution was further processed 
by adding 1.5 mL magnesium precipitating 
solution (6.05 g/L Trizma base, 5.85 g/L 
NaCl, and 100 g/L MgCl2∙6H2O, pH 9.274); 
the solution was vortexed and allowed to stand 
for 10 min. The precipitate was centrifuged for 
5 min at 2,000 rpm and the supernatant was 
removed. The pellet was washed three times 
by resuspending it in 1.5 mL washing solu-
tion (precipitate solution with pH adjusted 
to 8.772), centrifuging it at 2,000 rpm for 
5 min, and removing the supernatant. We 
assessed the tube with 750 µL serum and the 
pellet precipitated from 750 µL dialysate by 
gamma counting and compared the results 
with control incubations.
Model development. HPT axis.  We 
constructed the BBDR-HPT axis model in   
acslXtreme, version 2.4 (AEgis Technologies, 
Huntsville, AL) and solved it using the Gear 
algorithm for stiff systems. The model for 
dietary iodide and the thyroid axis was used as 
previously described (McLanahan et al. 2008). 
Briefly, this BBDR-HPT axis model includes 
submodels for dietary iodide, TSH, and the 
thyroid hormones T4 and T3 (Figure 1). The 
submodels combine to form a simplified, 
quantitative description of the thyroid axis in 
the adult rat. Regulatory and compensatory 
effects of TSH were empirically described for 
several thyroidal processes, including TSH 
stimulation of a) NIS thyroidal iodide uptake, 
b) formation of thyroid hormone precursors, 
and c) thyroid hormone secretion. The TSH/
T4 negative feedback loop is described using 
the relationship of serum total T4 (TT4) and 
TSH, as well as the metabolism of thyroid 
hormones with recycling of iodide.
We developed the BBDR-HPT axis model 
(McLanahan et al. 2008) to predict perturba-
tions in serum TT4, total T3 (TT3), TSH, and 
total thyroidal iodide content that resulted 
from a decrease in dietary iodide intake. 
Normal laboratory rat iodide intake is approxi-
mately 20 µg/day. Figure 2 shows a model 
simulation up to 28 days for Simonsen Albino 
rats placed on a diet containing 0.33 µg iodide 
per day from day 0 through day 28 (Okamura 
et al. 1981).
Perchlorate. Instead of the more elaborate 
modeling approach implemented by Merrill 
et al. (2003), a simple model structure for 
ClO4
– was constructed (Figure 3), similar to 
the approaches reported by Crump and Gibbs 
(2005) and Lorber (2008). This PBPK model 
consisted of three compartments: plasma, 
thyroid, and the rest of the body. ClO4
– is   
rapidly absorbed after oral administra-
tion and is distributed throughout the body 
but excreted unchanged through the urine 
(Wolff 1998). Urinary excretion of ClO4
– is 
described by first-order clearance from the 
plasma. The thyroid gland is described with a 
blood and tissue compartment using diffusion 
limitation and active uptake into the thyroid 
via the NIS. Several studies have shown that 
ClO4
– and 36ClO4
– are transported into the 
thyroid via the NIS, and an increased uptake 
has been observed in rats administered TSH 
and ClO4
– (Anbar et al. 1959; Chow et al. 
1969; Chow and Woodbury 1970; Dohan 
et al. 2007; Goldman and Stanbury 1973; 
Tran et al. 2008; Yu et al. 2002).
BBDR-HPT axis and ClO4
– PBPK 
model integration. We linked the PBPK 
model for ClO4
– with the BBDR-HPT axis 
model (McLanahan et al. 2008) by competi-
tion between ClO4
– and iodide at the NIS 
protein. Equations 1 and 2 describe, respec-
tively, the competitive interaction between 
ClO4
– and the NIS protein and TSH stimula-
tion of NIS activity:
     
rTNISi =
VmaxTi
TSH ×Cvti
Cvti + K mi × 1+
Cvtp
K ip
⎛
⎝
⎜
⎞
⎠
⎟
 
[1]
     
VmaxTi
TSH =
VmaxTi ×C ATSH
K NIS
TSH +C ATSH  
[2]
where rTNISi is the rate of iodide actively 
transported into the thyroid via NIS (nano-
moles per hour), Cvti is the free concentration 
of iodide in thyroid blood (nanomoles per 
liter), Kmi is the affinity constant of iodide 
for the NIS (nanomoles per liter), Cvtp is the 
concentration of ClO4
– in the thyroid blood 
(nanomoles per liter), Kip is the inhibition 
constant of ClO4
– for NIS iodide transport 
(nanomoles per liter), Vmax Ti is the maxi-
mum rate of NIS iodide uptake (nanomoles 
per hour), CATSH is the serum concen-
tration of TSH (nanomoles per liter), and 
KT
N
S
I
H
S is the concentration of TSH that gives 
rise to half-maximal rate of NIS transport 
of iodide (nanomoles per liter). We previ-
ously simultaneously optimized Vmax Ti 
Figure 2. BBDR-HPT axis model simulation (lines) of 
HPT axis alterations in serum TT4, TT3, and TSH and 
thyroid iodide up to 28 days after administration of a 
low-iodide diet (0.33 µg/day). Data (mean ± SD) are 
adapted from Okamura et al. (1981) and are offset at 
days 14 and 28 to aid in visualization of data.
100
10
1
0.1
05 10 15 20 25
Time (days)
S
e
r
u
m
T
T
4
 
a
n
d
 
T
T
3
 
(
n
g
/
m
L
)
,
s
e
r
u
m
 
T
S
H
 
(
f
o
l
d
 
c
h
a
n
g
e
)
,
t
o
t
a
l
 
t
h
y
r
o
i
d
 
i
o
d
i
d
e
 
(
µ
g
)
Serum TT4
Thyroid 127I
Serum TSH
Serum TT3
Figure 3. ClO4
– PBPK model structure for the adult 
male rat. ClO4
– (intravenous or oral drinking water 
dose) enters the plasma (Dose), where it is dis-
tributed to tissues or excreted in urine. Thyroid is 
modeled as diffusion limited, with active uptake 
(bold arrow) into the thyroid via the NIS. The “Rest 
of Body” compartment is a flow-limited compart-
ment and includes all other body tissues in which 
ClO4
– may distribute. Double thin arrows represent 
passive diffusion. Abbreviations: CA, concentration 
of ClO4
– in arterial blood; CvBody, concentration of 
ClO4
– in venous blood leaving the rest of the body 
compartment; Cvt, concentration of ClO4
– in venous 
blood leaving thyroid; QC, cardiac output; QBody, 
blood flow to the rest of the body; QT, blood flow to 
the thyroid.
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(nanomoles per hour) and KT
N
S
I
H
S (nanomoles 
per liter) (McLanahan et al. 2008) to euthy-
roid, dietary-iodine–sufficient (~ 20 µg/day) 
rat data for serum and thyroid iodide reported 
by Eng et al. (1999) and McLanahan et al. 
(2007), respectively. The other parameter, 
NIS affinity constant for iodide (Kmi, nano-
moles per liter) in Equation 1 was obtained 
from Gluzman and Niepomniszcze (1983) as 
reported by McLanahan et al. (2008).
We used an equation similar to Equation 1 
to model iodide’s inhibition of the uptake 
of ClO4
– via the NIS; however, the effect of 
iodide on transport of ClO4
– into the thyroid 
is minimal because ClO4
– has a higher affi- 
nity for the NIS protein compared with iodide 
(1,500 nmol ClO4
–/L vs. 31,519 nmol I/L).
Model parameter values. We obtained 
physiologic parameters (Table 1) for tis-
sue volumes and blood flows from previ-
ous studies (Brown et al. 1997; Everett et al. 
1956; Malendowicz and Bednarek 1986; 
McLanahan et al. 2007, 2008). The BBDR–
HPT axis model parameters had been cali-
brated for the euthyroid adult rat previously 
and used to describe iodide-deficient condi-
tions (McLanahan et al. 2008).
Table 2 shows model parameters for 
ClO4
–. We set the affinity constant, Kip, for 
the inhibition of iodide uptake by ClO4
– equal 
to Kmp, the measured affinity constant for 
ClO4
– and the NIS. A Kmp value of 1.5 µM 
was used, which was reported as an inhibition 
affinity constant for uptake of radiolabeled 
iodide in thyroid cells (Kosugi et al. 1996). 
We calculated a ClO4
– tissue:blood parti-
tion coefficient for the body compartment 
(minus the thyroid and plasma) by weight-
ing the partition coefficients based on tissue 
volume for tissue:blood partition coefficient 
values reported in Merrill et al. (2003) for the 
adult male rat. Optimization was carried out 
using acslXtreme parameter estimation tool 
kit, using 36ClO4
– kinetic data reported by 
Yu et al. (2002), who administered a single 
intravenous bolus dose of 3.3 mg/kg 36ClO4
–. 
Optimized values were obtained for Vmax Tcp, 
the maximal rate of uptake of 36ClO4
– into 
the thyroid and urinary clearance constant, 
and for ClUcp, a term used to describe the 
rate of excretion of 36ClO4
– in urine. The 
ClUcp value was obtained by fitting both the 
urinary excretion of 36ClO4
– and serum con-
centrations of 36ClO4
–.
Experimental simulations. Yu et al. 
(2002) administered 0, 0.1, 1, 3, and 10 mg 
ClO4
–/kg/day in drinking water to adult male 
Sprague-Dawley rats and determined serum 
TT4, fT4, TT3, TSH, and ClO4
– concentra-
tions after exposures of 1, 5, and 14 days. We 
did not consider the Yu et al. (2002) data for 
fT4 for this study because the increase in fT4 
with ClO4
– concentration is considered to be 
erroneous owing to a nondialysis method. The 
problem with this method has been previously 
discussed (Fisher et al. 2006). In addition, 
Männistö et al. (1979) administered ClO4
– at 
a rate of 15 mg/kg/day in drinking water to 
adult male Sprague-Dawley rats and measured 
serum TT4, TT3, and TSH after exposure for 
0, 2, 4, 6, 9, and 14 days. The BBDR-HPT/
ClO4
– model was configured to simulate these 
experiments. Ingestion of ClO4
– in drinking 
water took place over a 12-hr period.
Results
Laboratory binding and displacement experi­
ments. ClO4
– had little or no effect on dis-
placing 125I-T4 from serum proteins for both 
human and rats [see Supplemental Material, 
Figure 1 (http://www.ehponline.org/members/ 
2009/0800111/suppl.pdf)] across the rele-
vant range of ClO4
– concentrations tested 
(1–300 µg/mL). The highest concentration 
tested, 300 µg/mL, is 30 times greater than 
the range of interest for ClO4. Thus, older 
studies that examined high doses of ClO4
–
probably caused a displacement in protein-
bound T4, but for the concentration range of 
interest, 0.01–1.0 µg/mL (corresponding to 
a ClO4
– dose of 0.01–10 mg/kg/day), there 
appears to be little displacement of protein-
bound T4 by ClO4
–. We found no significant 
differences by analysis of variance for either 
rat (p = 0.13) or human (p = 0.96) serum. 
Therefore, this MOA was not explored in the 
computational analysis.
PBPK model predictions. Figure 4 shows 
model-predicted and laboratory-observed 
serum and thyroid 36ClO4
– concentra-
tions and cumulative urinary excretion of 
36ClO4
–after a single intravenous bolus dose 
of 3.3 mg/kg 36ClO4
–. We obtained these 
successful predictions of thyroidal and serum 
concentrations of 36ClO4
– and urinary clear-
ance using an optimized Vmax Tcp value of 
1,800 nmol/hr/kg0.75 and an optimized 
ClUcp value of 0.007 L/hr/kg0.25 (Table 2). 
Simulations of ClO4
– in serum and the thy-
roid gland were similar to previous model 
findings of Merrill et al. (2003) for the drink-
ing water dose groups of 0.1, 1.0, 3.0, and 
10 mg/kg/day that were originally reported by 
Yu et al. (2002) (data not shown).
Table 1. Physiologic parameters for the adult rat perchlorate model.
Parameter  Value  Source
Tissue volumes (V)
  Plasma, VPl (% BW)  4.44  Brown et al. 1997, Everett et al. 1956
  Thyroid, VTc (% BW)  0.005  McLanahan et al. 2007
  Thyroid blood, VTBc (% VT)  15.7  Malendowicz and Bednarek 1986
  Rest of body, VBody (L)  BW – VT – VPl
Blood flows (Q)
  Cardiac output, QCc (L/hr/kg0.75)  14.0  Brown et al. 1997
  Thyroid, QTc (% QC)  1.6a  Brown et al. 1997
  Rest of body, QBody  QC – QT
BW, body weight; VT, volume of thyroid; QC, cardiac output; QT, blood flow to thyroid
aHuman value.
Table 2. Compound-specific parameters.
Parameter  Value  Source
Partition coefficient (dimensionless)
  Body:blood, PBp  0.416a  Merrill et al. 2003
Permeability area cross-product (L/hr/kg0.75)
  Iodide, thyroid blood:thyroid tissue, PATci  1 × 10–4  McLanahan et al. 2008
  ClO4
–, thyroid blood:thyroid tissue, PATcp  2.8 × 10–4  Merrill et al. 2003
Affinity constants (nmol/L)
  Iodide, thyroid NIS, Kmi  3.15 × 104  Merrill et al. 2003, Gluzman and 
      Niepomniszcze 1983
  ClO4
–, thyroid NIS, Kmp  1.5 × 103  Kosugi et al. 1996
Maximum velocities (nmol/hr/kg0.75)
  Iodide, thyroid NIS, Vmax Tci  5.7 × 103  McLanahan et al. 2008
  ClO4
–, thyroid NIS, Vmax Tcp  1.8 × 102  Optimized
Clearance (L/hr/kg0.25)
  Iodide, urinary excretion, ClUci  5 × 10–3  McLanahan et al. 2008
  ClO4
–, urinary excretion, ClUcp  7.0 × 10–2  Optimized
aWeighted based on PBPK model partition coefficients. Data from Merrill et al. (2003).
Figure 4. Serum and thyroid concentration and 
cumulative urinary excretion of 36ClO4
– after a 
3.3-mg/kg intravenous dose. Lines represent model 
predictions. Data (mean ± SD) are from Yu et al. 
(2002).
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HPT response predictions: testing the 
hypothesis. We linked the ClO4
– model with 
the BBDR-HPT axis model that we previ-
ously calibrated to predict serum TT4, TT3, 
TSH, and total thyroid iodide for sufficient 
and insufficient dietary iodide intakes and 
evaluated the ability of the combined model 
to predict ClO4
–-induced HPT axis distur-
bances. The hypothe  sis was that the BBDR-
HPT/ClO4
– model would predict the HPT 
axis disturbances based on competitive inhi-
bition of thyroidal uptake of dietary iodide 
(Equation 1) for ClO4
– drinking water dose 
rates reported by Männistö et al. (1979) 
(15 mg/kg/day) and Yu et al. (2002) (0.1, 1, 
3, 10 mg/kg/day). In this case, the BBDR-
HPT/ClO4
– model failed to predict the HPT 
axis responses. Dose-dependent increases in 
serum TSH concentrations were severely 
underpredicted, and dose-dependent decreases 
in serum TT4 concentrations were also under-
predicted (Figure 5A,B). The small decrease 
in serum TT3 in response to 10 mg/kg/day 
ClO4
– was better predicted by the model 
[see Supplemental Material, Figure 2 (http://
www.ehponline.org/members/2009/0800111/
suppl.pdf)].
Yu et al. (2002) reported dose-dependent 
serum TSH increases ranging from 60% 
for the lowest dose to 174% for the highest 
dose compared with controls after 1 day of 
ClO4
– treatment. For all dose groups, serum 
TSH level continued to increase by day 5 
of treatment, with the exception of the 0.1 
mg/kg/day dose group. By day 14 of treat-
ment, TSH concentrations were in decline 
relative to the peak measured TSH concentra-
tions. Männistö et al. (1979) reported that 
15 mg/kg/day caused serum TSH levels to 
increase by 18% on day 2 of treatment and 
by 96% on day 14 (Figure 5C). These meas-
ured TSH concentrations are in stark contrast 
to the model-predicted values (Figure 5C). 
The model-simulated serum TSH concentra-
tions were predicted to increase only by 2–6% 
after 1 day of treatment and by 21–36% after 
14 days of treatment with the highest ClO4
– 
doses (10 and 15 mg/kg/day; Figure 5C).
Similar to the TSH findings, the dose-
  dependent decline in serum TT4 concentra-
tions reported by Yu et al. (2002) ranged from 
6% for the lowest dose to 24% for the highest 
dose after 1 day of ClO4
– treatment. Consistent 
with the increases in serum TSH on day 5, all 
treatment groups, except for the 0.1 mg/kg/
day ClO4
– dose group, displayed a continued 
decline in serum TT4 concentrations. By day 
14 of ClO4
– treatment, TT4 levels were recov-
ering (Figure 5A). Model predictions of serum 
TT4 concentrations were also in disagree-
ment with observations. The model-predicted 
decreases in serum TT4 concentrations were 
only 2–6% by day 1 of treatment and 13–26% 
by day 14 for the 10- and 15-mg/kg/day ClO4
– 
dose groups. Although the model-predicted 
and observed serum TT4 concentrations were 
in agreement for the 10-mg/kg/day group by 
day 14, the temporal aspect of the TT4 pertur-
bations was not predicted (Figure 5C).
The model-predicted interaction of ClO4
– 
(competitive inhibition) on thyroidal uptake 
of dietary iodide (Table 3) demonstrated the 
nonlinear uptake behavior of dietary iodide that 
is described by Michaelis-Menten kinetics for 
each anion. NIS-mediated thyroidal uptake of 
dietary iodide (micrograms per day) was pre-
dicted to be similar on days 1 and 14 (Table 3), 
with a slight increase on day 14 because of 
TSH stimulation of the NIS for the two highest 
ClO4
– doses (10 and 15 mg/kg/day). Although 
thyroidal iodide stores were not reported by Yu 
et al. (2002) and Männistö et al. (1979), only a 
6% and 12% depletion was predicted to occur 
after 1 day and 2 weeks of treatment of ClO4
– 
for dose rates of 10 and 15 mg/kg/day, respec-
tively (Table 3). The model-predicted depletion 
of thyroidal iodide stores was 33% and 46% by 
day 14 for these two doses, respectively.
The model-predicted percent inhibition 
in thyroidal uptake of dietary iodide was pre-
dicted to range from 26% for the 0.1 mg/kg 
ClO4
– dose group to 96% and 97% inhibition 
for the two highest dose groups (Table 3).
Is ClO4
– altering thyroid hormone secre-
tion? The best approach to answer this question 
would be to design studies focused on evaluat-
ing the status of the thyroid gland for a known 
intake of dietary iodide, such as meas  uring the 
ratios of MIT and DIT, and thyroid hormones 
in animals treated with ClO4
–. Another equally 
important and time-intensive effort would be to 
develop a mechanistic-based model of the thy-
roid gland that would include explicit descrip-
tions of the synthesis and secretion pathways 
for thyroid hormones, for which some data are 
still lacking. Instead, we simply imposed “non-
mechanistic” conditions on the thyroid gland 
by limiting thyroid hormone production and 
asking whether the systemic concentrations 
of TT4 and TSH can be described by sim-
ply limiting thyroid hormone production and 
secretion. To account for inhibition of thyroid 
hormone production, we modified equation 14 
from McLanahan et al. (2008), which describes 
Figure 5. (A) Model predictions (lines) of serum T4 and TSH after exposure to 0.1, 1, or 3 mg/kg/day ClO4
– in drinking water. Data for TSH and T4 from Yu et al. 
(2002) (0.1, 1.0, 3.0 mg/kg/day). (B) A closer look at model simulations in A, expanding the y-axis. (C) Model predictions of serum T4 and TSH after exposure to 10 or 
15 mg/kg/day ClO4
– in drinking water. Data (mean ± SD) for T4 and TSH for 10 mg/kg/day (~ 350 g rat) from Yu et al. (2002), and for 15 mg/kg/day 
(~ 200 g rat) from Männistö et al. (1979). The model does not predict the rapid changes in serum T4 and TSH observed in these studies.
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Table 3. Model predictions of daily NIS uptake of iodide into thyroid (µg/day) and total thyroid iodide stores 
(µg) for a 300-g adult rat, after 1 and 14 days of ClO4
– exposure in drinking water at various doses.
  Dose (mg/kg/day)
ClO4
– exposure  0  0.1  1  3  10  15
1 day 
  Average amount of iodide transported by NIS into thyroid (µg/day)  38  28  10  4.6  1.7  1.2a
  Total thyroid iodide stores (µg)  17.0  17.0  16.9  16.8  16.0  14.9a
14 days 
  Average amount of iodide transported by NIS into thyroid (µg/day)  38  28  10  4.6  1.9  1.5
  Total thyroid iodide stores (µg)  17.1  17.0  16.9  16.4  11.4  9.31
aModel simulation for 2 days of exposure to 15 mg/kg/day. Data from Männistö et al. (1979). McLanahan et al.
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the overall rate of thyroid hormone production 
(rTHprod, nanomoles per hour), by the addi-
tion of a proportional inhibition term (INHp), 
such that
 rTHprod = kIB
TSH × CATSH × CTBi × INHp,  [3]
where kIB
TSH (square liters/nanomole per hour) is 
a linear rate term, CATSH (nanomoles per liter) 
is the concentration of TSH in the serum, and 
CTBi (nanomoles per liter) is the bound con-
centration of iodide in the thyroid as thyroid 
hormone precursors. The production rate of T4 
and T3 was described as a fraction of the total 
production rate, and the proportion of T4 and 
T3 changes as a result of depletion of thyroidal 
iodide stores (McLanahan et al. 2008).
Figure 6A shows the 10-mg/kg/day dose 
group (Yu et al. 2002) model predictions for 
TT4 when a 25% (INHp = 0.75) or 50% 
(INHp = 0.50) inhibition of thyroid hormone 
synthesis is tested using the model. A 50% 
decrease in thyroid hormone production rate 
appears to describe the decreased TT4 con-
centrations for the first 5 days of exposure, but 
for serum TSH (Figure 6B) 90% inhibition 
of thyroid hormone synthesis did not describe 
the kinetic behavior for TSH. Serum TT3 
was predicted fairly well without imposing 
inhibition of thyroid hormone production; 
however, a 25% decrease in thyroid hormone 
production provided a slightly better fit to 
the Yu et al. (2002) 10 mg/kg/day dose group 
[see Supplemental Material, Figure 2 (http://
www.ehponline.org/members/2009/0800111/
suppl.pdf)]. This simple simulation exercise 
appears to suggest that thyroid hormone pro-
duction may be partially inhibited on a tran-
sient basis. However the relationship between 
TSH production and serum TT4 is complex 
and very different from dietary-iodide–induced 
hypothyroidism.
Discussion
In this article, we report on the use of com-
putational modeling analyses to examine the 
biological processes associated with disruption 
of an endocrine system, the HPT axis in the 
adult rat, by ClO4
–. The BBDR-HPT/ClO4
– 
model simulation results suggest that ClO4
– 
administered in drinking water (or by other 
routes of administration) interacts with the 
rat thyroid gland itself, potentially altering 
thyroid hormone synthesis or secretion. This 
interaction is in addition to blocking thyroid- 
al uptake of iodide. Current presumptions of 
a single MOA for ClO4
– on the HPT axis do 
not appear tenable based on these results.
Changes in serum TSH and TT4 after 
only 1 day of ClO4
– treatment were surpris-
ing because thyroidal iodide depletion was 
expected to be minimal over this time period, 
although 26–96% inhibition of NIS thyroidal 
iodide uptake was predicted by the model, 
which is in close agreement with Yu et al. 
(2002). The only reported effects of ClO4
– on 
thyroidal iodide content we found were those 
of Ortiz-Caro et al. (1983), who reported a 
decrease in thyroidal 127I of nearly 8% in rats 
administered 1,000 ppm ClO4
– in drinking 
water for 2 days and provided a low-iodide 
diet. A 10–15% decrease over 1 day is pre-
dicted by our model, if ClO4
– caused a 100% 
block of thyroidal uptake of dietary iodide. 
In comparison, for a severely iodide-deficient 
diet (0.3 µg I/day), it would take 7 days to 
deplete thyroid stores by 43% and result in 
a 35% decrease in serum T4 (McLanahan 
et al. 2008). This degree of perturbation in the 
HPT axis compares with the 10 mg/kg/day 
ClO4
– dose group after only 1 day of expo-
sure (Yu et al. 2002). In the iodide-deficient 
BBDR-HPT axis model (McLanahan et al. 
2008), the thyroidal iodide stores were closely 
related to iodide deficiency perturbations in 
the HPT axis. With ClO4
–, it is apparent that 
the HPT axis is disturbed before sufficient 
model-predicted depletion of thyroidal iodide 
stores. For iodide deficiency, slow depletion of 
thyroidal iodide stores was governed by iodide 
available for thyroidal uptake and the secretion 
and metabolism rates of thyroid hormones.
McNabb et al. (2004a, 2004b) reported 
on the dose-dependent thyroidal depletion 
of T4 from bobwhite quail chicks ingesting 
ClO4
–. This depletion in thyroidal T4 may 
have occurred because of the blocking effect 
of ClO4
– on thyroidal uptake of iodide, ClO4
– 
acting on the thyroid gland synthesis and secre-
tion of T4, or a combination of both modes of 
action. The idea that ClO4
– may affect thyroid 
hormone synthesis/secretion has previously 
been discussed (Hildebrandt and Halmi 1981; 
Wolff 1998). Greer et al. (1966) provided 
experimental evidence for a direct effect on 
ClO4
– on the rat thyroid gland in vitro. These 
authors reported that ClO4
– reduced forma-
tion of MIT and DIT in rat thyroid lobes 
when incubated with ClO4
–. They observed 
changes in MIT and DIT forma  tion for ClO4
– 
media concentrations starting at 10 mg/L with 
a reported 50% effective reduction of DIT at 
250 mg/L. By comparison, in vivo, rats ingest-
ing 1, 3, and 10 mg/kg/day ClO4
– in drinking 
water had measured serum ClO4
– concentra-
tions of approximately 0.3, 1.4, and 4.9 mg/L 
and thyroidal ClO4
– concentrations of 10, 50, 
and 176 mg/kg, respectively (Yu et al. 2002). 
Although difficult to compare, the in vitro 
media and in vivo serum ClO4
– concentrations 
suggest that the in vitro ClO4
–-induced changes 
in organification may be a high-dose effect of 
ClO4
–. Nevertheless, the data reported by Greer 
et al. (1966) demon  strate that interactions of 
ClO4
– and thyroid gland processes are possible.
Interestingly, Yu et al. (2002) also reported 
that when rats were administered an intra-
venous dose of 3 mg/kg of ClO4
–, serum TSH 
and TT4 concentrations were at control levels 
8 hr postdosing, but by 12 hr serum TSH con-
centrations increased and serum TT4 concen-
trations decreased. The secretion rate of iodide 
(as thyroid hormones) is about 0.5–1 µg over 
a 12-hr period, which suggests that thyroidal 
iodide stores may be depleted by only 5–8% 
when HPT axis perturbations were observed.
Männistö et al. (1979) administered   
propylthiouracil (PTU), MMI, potassium per-
chlorate (KClO4), and KI to rats in drinking 
water and measured serum TSH and TT4 at 
several time points over 14 days of treatment. 
KI and KClO4 both rapidly depleted serum 
TT4 concentrations by day 2 of treatment. 
KI animals recovered by day 4 of treatment, 
whereas the KClO4 rats did not, and serum 
TT4 concentrations remained low, similar 
to MMI and PTU animals, over 14 days of 
treatment. Excess iodide is well known for 
this Wolff-Chaikoff effect, which is associated 
with a transient “shutdown” in the thyroid 
gland (Wolff and Chaikoff 1948). MMI and 
PTU interact with thyroid peroxidase in vitro, 
but ClO4
– does not (Magnusson et al. 1984).
A recent in vitro study conducted by 
Tonacchera et al. (2004) in Chinese hamster 
ovary cells transfected with human NIS affirm 
that ClO4
– inhibits iodide uptake in a competi-
tive fashion, with potencies 15, 30, and 
Figure 6. Serum T4 model predictions (A; lines) and serum TSH model predictions (B; lines) shown as 
percentage of control (100%) values at a ClO4
– dose of 10 mg/kg/day and varying degrees of inhibition of 
T4 and T3 synthesis and secretion from the thyroid (25, 50, or 90%). These model predictions also include 
inhibition of NIS thyroidal iodide uptake by ClO4
–. Data (mean ± SD) from Yu et al. (2002).
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240 times greater than the related compounds 
thiocyanate (SCN–), iodide, and nitrate   
(NO3
–), respectively. The relative concentra-
tions of these monovalent anions determine 
the ability of NIS to transport iodide, and 
because SCN– and NO3
– are present in human 
sera at greater concentrations than ClO4
–, 
several researchers (De Groef et al. 2006; 
Gibbs 2006) have suggested that SCN– and 
NO3
– are more likely than ClO4
– to adversely 
affect (e.g., correlate with) thyroid function. 
However, Blount et al. (2006) reported cor-
relations between ClO4
– and serum TT4 and 
TSH, no correlation with nitrate, but a nega-
tive association of TT4 with thiocyanate. That 
a decrease in serum TT4 and increase in serum 
TSH correlated with ClO4
– but not with the 
other monovalent anions suggests that ClO4
– 
may act through another MOA in addition to 
simple competitive inhibition.
TSH secretion from the pituitary is con-
trolled by thyroid-releasing hormone (TRH) 
from the hypothalamus, and secretion of both 
TSH and TRH is partially controlled by thy-
roid hormones derived from serum. Using a 
quantitative evaluation of the pulsatile nature 
of the HPT axis, Li et al. (1995) suggest that 
the feedback effects of thyroid hormones on the 
hypothalamus and control of TRH secretion 
are much smaller than effects on the pituitary 
for control of TSH secretion. However, if TRH 
secretion is high, TRH may dominate the con-
trol of TSH secretion. In the case of ClO4
–, the 
current BBDR–HPT axis model, calibrated for 
iodide deficiency, would need to be calibrated 
to explicitly include differential control of TSH 
secretion by both TRH and thyroid hormones.
Hypothalamic TRH does drive pitui-
tary TSH secretion; however, details in rats, 
humans, and other species are not sufficient 
to distinguish between hypothalamic- and 
pituitary-derived TSH secretion. Measuring 
pituitary portal blood TRH is not realistic. A 
few attempts in rodents, using extreme surgi-
cal techniques, have been carried out, but not 
in reference to perturbations of the HPT axis. 
This aspect of HPT axis regulation remains 
a data gap. Eisenberg et al. (2008) recently 
published a control systems simulation model 
of the HPT axis feedback system in humans. 
They also did not include the hypothalamic 
aspect in their feedback simulator because of a 
lack of information. In our BBDR-HPT axis 
model (McLanahan et al. 2008), the TRH 
aspect of TSH production is embedded or 
lumped with the equation that describes the 
relationship between serum TSH and TT4 
concentrations (Equation 3). Eisenberg et al. 
(2008) also lumped the hypothalamic contri-
bution to describe TSH secretion in humans.
In conclusion, our computational analysis 
indicates that ClO4
– alters the HPT axis by 
blocking iodide transport and by interacting in 
some fashion with hormone production/release 
from the thyroid. The present description of 
synthesis and secretion of thyroid hormones 
(Equation 3) is simple, and if the thyroid 
gland itself is a target of ClO4
–, as the model-
ing suggests, then a more complex description 
of the thyroid hormone synthesis and secre-
tion process will be required. Our goal in this 
effort was to impose “non  mechanistic” out-
comes to better understand what conditions 
may help explain the observed ClO4
– dose 
response. A significant correlation of effects 
of ClO4
– with serum thyroid hormones in 
humans has yet to be confirmed, so the impor-
tance of this potential MOA in humans is not 
known. Computational models can provide 
quantitative tools to evaluate possible MOAs 
of ClO4
– on the HPT axis. This evaluation 
would be supported by conducting specific 
studies to develop a quantitative mathematical 
description of the MOA, along with studies 
that measure temporal perturbations in several 
HPT axis end points. Studies are needed that 
evaluate the molecular biology of the genes 
within the thyroid gland, coupled with meas-
ure  ment of thyroid hormone precursors and 
thyroid hormones using modern analytical 
techniques such as liquid   chromatography/
mass spectrometry. These studies need to be 
completed for known iodine intake rates along 
with sufficient doses and time points to con-
struct a temporal dose–response curve after 
ClO4
– exposure via drinking water.
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